This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Management of persistent diarrhoea on return

Authoring team

  • in nearly 3% of travellers who have returned from developing countries, diarrhoea persists for more than 14 days. In 1-2% of travellers diarrhoea persists for more than 14 days (1)

  • persistent diarrhoea is defined as diarrhoea lasting for 2-4 weeks (2)
    • aetiology of persistent diarrhoea varies according to the region (developing or developed), recent travel history, and the immune function of the underlying host.
      • infections are the commonest cause
        • enteropathogenic E. coli (EPEC) and enteroaggregative E. coli (EAEC) common in developing countries (Campylobacter and Salmonella are rare)
        • viruses (Norovirus and rotavirus) - common in developed countries especially in children
        • intestinal protozoa
          • Giardia and Cryptosporidium
          • Entamoeba and Isospora (1)

  • if a patient has employment which involves handling food then he/she should be advised to stay off work until the cause of persistent diarrhoea is identified and treated
  • if a case of dysentery is suspected then this should be notified
  • a clinician should consider the possibility of protozoa infection in cases of persistent diarrhoea e.g. G lamblia, E. histolytica
  • a stool sample should be sent (with travel history on the request form) for standard culture and microscopy for ova, cysts and parasits
  • if the stool sample is negative then empirical treatment with tinidazole or metronidazole has the advantage that it will treat pathogens such as G. lamblia which can be difficult to identify on stool examination
  • if a pathogen is isolated then appropriate antimicrobial treatment can be initiated
  • if diarrhoea is persistent despite treatment then specialist referral is appropriate e.g. to a gastroenterologist or infectious diseases specialist
    • possible further investigations include sigmoidoscopy and biopsy, serology for E. histolytica and Yersinia entercolitica, and, if necessary, small intestinal biopsy and microscopy of duodenal aspirate

Reference:

  1. Drugs and Therapeutics Bulletin (2002), 40(5), 36-38.
  2. Guandalini S, Vaziri H 2011. Diarrhea. Diagnostic and therapeutic advantages. 1st edition

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.